_id
6919f16e3c536f8df23185e6
Ticker
9VC.XETRA
Name
ATAI Life Sciences NV
Exchange
XETRA
Address
Prof. J.H. Bavincklaan 7, Amstelveen, Netherlands, 1183 AT
Country
Germany
Sector
Healthcare
Industry
Biotechnology
Currency
EUR
Website
https://www.ataibeckley.com
Description
Atai Beckley N.V., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health treatments in the United States, Germany, and Canada. The company develops BPL-003, an intranasal formulation of the benzoate salt form of mebufotenin that is in Phase 2a and 2b clinical studies for treatment resistant depression (TRD) and alcohol use disorder; RL-007, an orally bioavailable compound, which is a pro-cognitive neuromodulator in Phase 2b trial for cognitive impairment associated with schizophrenia; and ELE-101, a serotonergic psychedelic in Phase 2a trial for the treatment of major depressive disorder. It is also developing VLS-01, an oral transmucosal film formulation of N,N-Dimethyltryptamine in Phase 2 clinical study to treat TRD; EMP-01, an oral formulation of R-3,4-methylenedioxy-methamphetamine that is in Phase 2 clinical study for social anxiety disorder; and EGX-A & EGX-B, which are non-hallucinogenic 5-HT2A receptor agonists in preclinical studies for TRD. In addition, the company offers COMP360 for psilocybin therapy; and GRX-917 for the treatment of anxiety, depression, and various neurological disorders. The company was formerly known as ATAI Life Sciences N.V. and changed its name to Atai Beckley N.V. in November 2025. Atai Beckley N.V. was founded in 2018 and is headquartered in Amstelveen, The Netherlands.
Last Close
3.468
Volume
293
Current Price
3.426
Change
-1.2110726643598562
Last Updated
2025-12-30T11:51:49.293Z
Image
https://logo.clearbit.com/www.ataibeckley.com
Ipo Date
-
Market Cap
1290018176
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
749000
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
29156000
Operating Income
-28407000
Interest Expense
0
Pretax Income
-60967000
Net Income
-61074000
Eps
-0.25401223521795835
Dividends Per Share
-
Shares Outstanding
363214602
Income Tax Expense
-
EBITDA
-
Operating Margin
-3792.656875834446
Total Other Income Expense Net
-33064000
Cash
30402000
Short Term Investments
84204000
Receivables
-
Inventories
-
Total Current Assets
130666000
Property Plant Equipment
5672000
Total Assets
239820000
Payables
5370000
Short Term Debt
-
Long Term Debt
-
Total Liabilities
79912000
Equity
159751000
Bs_currency_symbol
USD
Depreciation
233000
Change In Working Capital
-1255000
Cash From Operations
-23261000
Capital Expenditures
5363000
Cash From Investing
-
Cash From Financing
59744000
Net Change In Cash
-31538000
Cf_currency_symbol
USD
PE
-
PB
5.156386964475966
ROE
-38.23074659939531
ROA
-25.466599949962472
FCF
-28624000
Fcf Percent
-38.21628838451269
Piotroski FScore
1
Health Score
26
Deep Value Investing Score
2.5
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
1
Momentum Investing Score
2.5
Net Net Investing Score
2.5
Quality Investing Score
2
Value Investing Score
4
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
749000
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
29156000
Quarters > 0 > income Statement > operating Income
-28407000
Quarters > 0 > income Statement > interest Expense
0
Quarters > 0 > income Statement > pretax Income
-60967000
Quarters > 0 > income Statement > net Income
-61074000
Quarters > 0 > income Statement > eps
-0.25401223521795835
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
240437237
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-3792.656875834446
Quarters > 0 > income Statement > total Other Income Expense Net
-33064000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
30402000
Quarters > 0 > balance Sheet > short Term Investments
84204000
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
130666000
Quarters > 0 > balance Sheet > property Plant Equipment
5672000
Quarters > 0 > balance Sheet > total Assets
239820000
Quarters > 0 > balance Sheet > payables
5370000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
79912000
Quarters > 0 > balance Sheet > equity
159751000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-61074000
Quarters > 0 > cash Flow > depreciation
233000
Quarters > 0 > cash Flow > change In Working Capital
-1255000
Quarters > 0 > cash Flow > cash From Operations
-23261000
Quarters > 0 > cash Flow > capital Expenditures
5363000
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
59744000
Quarters > 0 > cash Flow > net Change In Cash
-31538000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.25401223521795835
Quarters > 0 > ratios > PB
5.156386964475966
Quarters > 0 > ratios > ROE
-38.23074659939531
Quarters > 0 > ratios > ROA
-25.466599949962472
Quarters > 0 > ratios > FCF
-28624000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-38.21628838451269
Quarters > 0 > health Score
26
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
719000
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
25964000
Quarters > 1 > income Statement > operating Income
-25245000
Quarters > 1 > income Statement > interest Expense
264000
Quarters > 1 > income Statement > pretax Income
-27653000
Quarters > 1 > income Statement > net Income
-27729000
Quarters > 1 > income Statement > eps
-0.13064643525413275
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
212244597
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-3511.1265646731576
Quarters > 1 > income Statement > total Other Income Expense Net
-2392000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
61940000
Quarters > 1 > balance Sheet > short Term Investments
34003000
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
102681000
Quarters > 1 > balance Sheet > property Plant Equipment
5702000
Quarters > 1 > balance Sheet > total Assets
189204000
Quarters > 1 > balance Sheet > payables
4039000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
45279000
Quarters > 1 > balance Sheet > equity
143738000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-27729000
Quarters > 1 > cash Flow > depreciation
227000
Quarters > 1 > cash Flow > change In Working Capital
7798000
Quarters > 1 > cash Flow > cash From Operations
-14094000
Quarters > 1 > cash Flow > capital Expenditures
5127000
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
7757000
Quarters > 1 > cash Flow > net Change In Cash
3653000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.13064643525413275
Quarters > 1 > ratios > PB
5.058857012912383
Quarters > 1 > ratios > ROE
-19.291349538744104
Quarters > 1 > ratios > ROA
-14.65560981797425
Quarters > 1 > ratios > FCF
-19221000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-26.73296244784423
Quarters > 1 > health Score
30
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
1555000
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
21897000
Quarters > 2 > income Statement > operating Income
-20342000
Quarters > 2 > income Statement > interest Expense
900000
Quarters > 2 > income Statement > pretax Income
-26309000
Quarters > 2 > income Statement > net Income
-26431000
Quarters > 2 > income Statement > eps
-0.13230350274361954
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
199775512
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-1308.1672025723472
Quarters > 2 > income Statement > total Other Income Expense Net
-5253000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
48287000
Quarters > 2 > balance Sheet > short Term Investments
49917000
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
115978000
Quarters > 2 > balance Sheet > property Plant Equipment
5587000
Quarters > 2 > balance Sheet > total Assets
195783000
Quarters > 2 > balance Sheet > payables
2705000
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
9300000
Quarters > 2 > balance Sheet > total Liabilities
43509000
Quarters > 2 > balance Sheet > equity
152053000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-26431000
Quarters > 2 > cash Flow > depreciation
216000
Quarters > 2 > cash Flow > change In Working Capital
-1729000
Quarters > 2 > cash Flow > cash From Operations
-17841000
Quarters > 2 > cash Flow > capital Expenditures
268000
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
59605000
Quarters > 2 > cash Flow > net Change In Cash
30782000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.13230350274361954
Quarters > 2 > ratios > PB
4.501265375309925
Quarters > 2 > ratios > ROE
-17.38275469737526
Quarters > 2 > ratios > ROA
-13.500150677025074
Quarters > 2 > ratios > FCF
-18109000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-11.645659163987139
Quarters > 2 > health Score
30
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
-5000
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
30352000
Quarters > 3 > income Statement > operating Income
-30357000
Quarters > 3 > income Statement > interest Expense
952000
Quarters > 3 > income Statement > pretax Income
-39184000
Quarters > 3 > income Statement > net Income
-38958000
Quarters > 3 > income Statement > eps
-0.23194842535847518
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
167959752
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
607140
Quarters > 3 > income Statement > total Other Income Expense Net
-8068000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
17505000
Quarters > 3 > balance Sheet > short Term Investments
44825000
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
80125000
Quarters > 3 > balance Sheet > property Plant Equipment
3869000
Quarters > 3 > balance Sheet > total Assets
159387000
Quarters > 3 > balance Sheet > payables
2616000
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
14133000
Quarters > 3 > balance Sheet > total Liabilities
42833000
Quarters > 3 > balance Sheet > equity
116297000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-38958000
Quarters > 3 > cash Flow > depreciation
225000
Quarters > 3 > cash Flow > change In Working Capital
-4035000
Quarters > 3 > cash Flow > cash From Operations
-24295000
Quarters > 3 > cash Flow > capital Expenditures
89000
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
154000
Quarters > 3 > cash Flow > net Change In Cash
-17458000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.23194842535847518
Quarters > 3 > ratios > PB
4.947935977299501
Quarters > 3 > ratios > ROE
-33.49871449822437
Quarters > 3 > ratios > ROA
-24.442394925558546
Quarters > 3 > ratios > FCF
-24384000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
4876.8
Quarters > 3 > health Score
48
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
308000
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
102474000
Annuals > 0 > income Statement > operating Income
-102166000
Annuals > 0 > income Statement > interest Expense
3124000
Annuals > 0 > income Statement > pretax Income
-148405000
Annuals > 0 > income Statement > net Income
-149269000
Annuals > 0 > income Statement > eps
-0.8887188640288062
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
167959752
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-33170.779220779215
Annuals > 0 > income Statement > total Other Income Expense Net
-43893000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
17505000
Annuals > 0 > balance Sheet > short Term Investments
44825000
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
80125000
Annuals > 0 > balance Sheet > property Plant Equipment
3869000
Annuals > 0 > balance Sheet > total Assets
159387000
Annuals > 0 > balance Sheet > payables
2616000
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
14133000
Annuals > 0 > balance Sheet > total Liabilities
42833000
Annuals > 0 > balance Sheet > equity
116297000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-149269000
Annuals > 0 > cash Flow > depreciation
473000
Annuals > 0 > cash Flow > change In Working Capital
-9200000
Annuals > 0 > cash Flow > cash From Operations
-82437000
Annuals > 0 > cash Flow > capital Expenditures
95000
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
5374000
Annuals > 0 > cash Flow > net Change In Cash
-17529000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-0.8887188640288062
Annuals > 0 > ratios > PB
4.917607122797665
Annuals > 0 > ratios > ROE
-128.3515481912689
Annuals > 0 > ratios > ROA
-93.65192895280042
Annuals > 0 > ratios > FCF
-82532000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-267.961038961039
Annuals > 0 > health Score
30
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
314000
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
-
Annuals > 1 > income Statement > operating Expenses
123340000
Annuals > 1 > income Statement > operating Income
-123026000
Annuals > 1 > income Statement > interest Expense
2656000
Annuals > 1 > income Statement > pretax Income
-39286000
Annuals > 1 > income Statement > net Income
-40224000
Annuals > 1 > income Statement > eps
-0.24227472841125816
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
166026396
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-39180.25477707006
Annuals > 1 > income Statement > total Other Income Expense Net
84549000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
45034000
Annuals > 1 > balance Sheet > short Term Investments
134223000
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
185592000
Annuals > 1 > balance Sheet > property Plant Equipment
2204000
Annuals > 1 > balance Sheet > total Assets
293478000
Annuals > 1 > balance Sheet > payables
4589000
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
17877000
Annuals > 1 > balance Sheet > total Liabilities
49162000
Annuals > 1 > balance Sheet > equity
242962000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-40224000
Annuals > 1 > cash Flow > depreciation
319000
Annuals > 1 > cash Flow > change In Working Capital
7469000
Annuals > 1 > cash Flow > cash From Operations
-84118000
Annuals > 1 > cash Flow > capital Expenditures
590000
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
-8355000
Annuals > 1 > cash Flow > net Change In Cash
-145579000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.24227472841125816
Annuals > 1 > ratios > PB
2.3267831116800157
Annuals > 1 > ratios > ROE
-16.55567537310361
Annuals > 1 > ratios > ROA
-13.70596773863799
Annuals > 1 > ratios > FCF
-84708000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-269.77070063694265
Annuals > 1 > health Score
35
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
233000
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
144663000
Annuals > 2 > income Statement > operating Income
-144430000
Annuals > 2 > income Statement > interest Expense
923000
Annuals > 2 > income Statement > pretax Income
-135182000
Annuals > 2 > income Statement > net Income
-152385000
Annuals > 2 > income Statement > eps
-0.9183364609062267
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
165935914
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
-61987.12446351931
Annuals > 2 > income Statement > total Other Income Expense Net
8700000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
190613000
Annuals > 2 > balance Sheet > short Term Investments
82496000
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
287145000
Annuals > 2 > balance Sheet > property Plant Equipment
1154000
Annuals > 2 > balance Sheet > total Assets
305441000
Annuals > 2 > balance Sheet > payables
2399000
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
15117000
Annuals > 2 > balance Sheet > total Liabilities
39675000
Annuals > 2 > balance Sheet > equity
260740000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-152385000
Annuals > 2 > cash Flow > depreciation
168000
Annuals > 2 > cash Flow > change In Working Capital
-3335000
Annuals > 2 > cash Flow > cash From Operations
-104467000
Annuals > 2 > cash Flow > capital Expenditures
1024000
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
20785000
Annuals > 2 > cash Flow > net Change In Cash
-171653000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.9183364609062267
Annuals > 2 > ratios > PB
2.1669547716882716
Annuals > 2 > ratios > ROE
-58.44327682749098
Annuals > 2 > ratios > ROA
-49.89015881954289
Annuals > 2 > ratios > FCF
-105491000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-452.7510729613734
Annuals > 2 > health Score
34
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
20376000
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
140701000
Annuals > 3 > income Statement > operating Income
-120325000
Annuals > 3 > income Statement > interest Expense
-
Annuals > 3 > income Statement > pretax Income
-136601000
Annuals > 3 > income Statement > net Income
-167808000
Annuals > 3 > income Statement > eps
-1.044380956550216
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
160677001
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
-590.5231645072635
Annuals > 3 > income Statement > total Other Income Expense Net
-16481000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
362266000
Annuals > 3 > balance Sheet > short Term Investments
0
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
375082000
Annuals > 3 > balance Sheet > property Plant Equipment
149000
Annuals > 3 > balance Sheet > total Assets
414166000
Annuals > 3 > balance Sheet > payables
6004000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
743000
Annuals > 3 > balance Sheet > total Liabilities
28207000
Annuals > 3 > balance Sheet > equity
376908000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-167808000
Annuals > 3 > cash Flow > depreciation
47000
Annuals > 3 > cash Flow > change In Working Capital
-7604000
Annuals > 3 > cash Flow > cash From Operations
-63246000
Annuals > 3 > cash Flow > capital Expenditures
1128000
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
409862000
Annuals > 3 > cash Flow > net Change In Cash
265020000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-1.044380956550216
Annuals > 3 > ratios > PB
1.4515616235394313
Annuals > 3 > ratios > ROE
-44.522270686745834
Annuals > 3 > ratios > ROA
-40.51708735144845
Annuals > 3 > ratios > FCF
-64374000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-3.1593050647820964
Annuals > 3 > health Score
35
Valuation > metrics > PE
-0.25401223521795835
Valuation > metrics > PB
5.156386964475966
Valuation > final Score
28.436130355240337
Valuation > verdict
71.9% Overvalued
Profitability > metrics > ROE
-38.23074659939531
Profitability > metrics > ROA
-46.74054459461528
Profitability > metrics > Net Margin
-81.5407209612817
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.5002284805728916
Risk > metrics > Interest Coverage
-0.8591519477377207
Risk > final Score
45
Risk > verdict
High
Liquidity > metrics > Current Ratio
24.332588454376165
Liquidity > metrics > Quick Ratio
24.332588454376165
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
29.41142987087617
Prev Valuations > 1
34.98734624690074
Prev Valuations > 2
30.52064022700499
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
30
Prev Risks > 0
-322
Prev Risks > 1
-30
Prev Risks > 2
-68
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T23:05:16.724Z
Earnings History > 0 > period
2026-03-31
Earnings History > 0 > report Date
2026-05-12
Earnings History > 0 > date
2026-03-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-12-31
Earnings History > 1 > report Date
2026-03-16
Earnings History > 1 > date
2025-12-31
Earnings History > 1 > before After Market
BeforeMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-
Earnings History > 1 > eps Estimate
-0.12
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-09-30
Earnings History > 2 > report Date
2025-11-13
Earnings History > 2 > date
2025-09-30
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.2402
Earnings History > 2 > eps Estimate
-0.12
Earnings History > 2 > eps Difference
-0.1202
Earnings History > 2 > surprise Percent
-100.1667
Earnings History > 3 > period
2025-06-30
Earnings History > 3 > report Date
2025-08-13
Earnings History > 3 > date
2025-06-30
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.1244
Earnings History > 3 > eps Estimate
-0.12
Earnings History > 3 > eps Difference
-0.0044
Earnings History > 3 > surprise Percent
-3.6667
Earnings History > 4 > period
2025-03-31
Earnings History > 4 > report Date
2025-05-14
Earnings History > 4 > date
2025-03-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.1425
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-13
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.149
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-13
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.3319
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-15
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.1549
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-03-28
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.1071
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-14
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
0.2611
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-10
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.1949
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-11
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.1982
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-03-24
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.278
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-10
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.2149
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-15
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.2235
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-05-16
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.2141
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-03-30
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.4839
Earnings History > 16 > eps Estimate
-
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-11-15
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.1656
Earnings History > 17 > eps Estimate
-
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-08-16
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.2596
Earnings History > 18 > eps Estimate
-
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
-
Atai Beckley N.V., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health treatments in the United States, Germany, and Canada. The company develops BPL-003, an intranasal formulation of the benzoate salt form of mebufotenin that is in Phase 2a and 2b clinical studies for treatment resistant depression (TRD) and alcohol use disorder; RL-007, an orally bioavailable compound, which is a pro-cognitive neuromodulator in Phase 2b trial for cognitive impairment associated with schizophrenia; and ELE-101, a serotonergic psychedelic in Phase 2a trial for the treatment of major depressive disorder. It is also developing VLS-01, an oral transmucosal film formulation of N,N-Dimethyltryptamine in Phase 2 clinical study to treat TRD; EMP-01, an oral formulation of R-3,4-methylenedioxy-methamphetamine that is in Phase 2 clinical study for social anxiety disorder; and EGX-A & EGX-B, which are non-hallucinogenic 5-HT2A receptor agonists in preclinical studies for TRD. In addition, the company offers COMP360 for psilocybin therapy; and GRX-917 for the treatment of anxiety, depression, and various neurological disorders. The company was formerly known as ATAI Life Sciences N.V. and changed its name to Atai Beckley N.V. in November 2025. Atai Beckley N.V. was founded in 2018 and is headquartered in Amstelveen, The Netherlands.
Stock Price
€0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AAtaiBeckley issues 2026 outlook, flags multiple clinical milestones - Proactive financial news
1/8/2026
AtaiBeckley issues 2026 outlook, flags multiple clinical milestones Proactive financial news
Read more →AtaiBeckley completes redomiciliation from Netherlands to US Proactive financial news
Read more →Showing 2 of 7
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of ATAI Life Sciences NV
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.12
Date
2025-09-30
EPS Actual
-0.2402
EPS Estimate
-0.12
EPS Difference
-0.1202
Surprise Percent
-100.1667%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
€ 0
Cost Of Revenue
€ 0
Gross Profit
€ 0
Operating Expenses
€ 0
Operating Income
€ 0
Interest Expense
€ 0
Pretax Income
€ 0
Net Income
€ 0
Income Tax Expense
€ 0
EBITDA
€ 0
Total Other Income Expense Net
€ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
€ 0
Short Term Investments
€ 0
Receivables
€ 0
Inventories
€ 0
Total Current Assets
€ 0
Property Plant Equipment
€ 0
Total Assets
€ 0
Payables
€ 0
Short Term Debt
€ 0
Long Term Debt
€ 0
Total Liabilities
€ 0
Equity
€ 0
(Last Updated 2025-09-30)
Net Income
€ 0
Depreciation
€ 0
Change In Working Capital
€ 0
Cash From Operations
€ 0
Capital Expenditures
€ 0
Cash From Investing
€ 0
Cash From Financing
€ 0
Net Change In Cash
€ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.